• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促性腺激素释放激素拮抗剂方案在多囊卵巢综合征患者中是否更优?一项 RCT 的荟萃分析。

Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.

机构信息

Department of Gynecology & Obstetrics, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

PLoS One. 2014 Mar 18;9(3):e91796. doi: 10.1371/journal.pone.0091796. eCollection 2014.

DOI:10.1371/journal.pone.0091796
PMID:24642641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3958392/
Abstract

OBJECTIVE

To review published randomized controlled trials (RCTs) evaluating the outcomes of in vitro fertilization/intra-cytoplasmic sperm injection (IVF/ICSI) utilization of gonadotropin-releasing hormone (GnRH) antagonists for ovarian stimulation in polycystic ovarian syndrome (PCOS) patients compared with classic luteal long agonist protocols.

DESIGN

A meta-analysis of prospective randomized trials published in English between 2002 and 2013.

PATIENT(S) AND INTERVENTIONS: Nine RCTs examining PCOS patients undergoing IVF/ICSI including 588 women who underwent long agonist protocols and 554 women who underwent GnRH antagonist protocols.

MAIN OUTCOME MEASURE(S): Clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR) and ovarian hyperstimulation syndrome (OHSS) rate.

RESULT(S): Nine RCTs were included in this analysis. The CPR-per-embryo transferred was similar in the two groups (relative risk (RR): 0.97, 95% confidence interval (CI): 0.85-1.10). Non-significant estimates comparing the two protocols were found for age, BMI, total dose of gonadotropin administered, number of days of stimulation and number of oocytes retrieved. After meta-analysis of 4 of the RCTs, it was concluded that a GnRH antagonist protocol is better than an agonist long protocol to reduce the rate of severe OHSS (odds ratio (OR): 1.56, 95% CI: 0.29-8.51).

CONCLUSION(S): With respect to CPR, a GnRH antagonist protocol is similar to a GnRH agonist long protocol. However, for severe OHSS, a GnRH antagonist protocol is significantly better in PCOS patients.

摘要

目的

回顾已发表的随机对照试验(RCT),评估促性腺激素释放激素(GnRH)拮抗剂在多囊卵巢综合征(PCOS)患者体外受精/卵胞浆内单精子注射(IVF/ICSI)促排卵中的应用与经典黄体期长激动剂方案相比的结局。

设计

2002 年至 2013 年发表的英语前瞻性随机试验的荟萃分析。

患者和干预措施

九项 RCT 检查接受 IVF/ICSI 的 PCOS 患者,包括 588 名接受长激动剂方案和 554 名接受 GnRH 拮抗剂方案的患者。

主要观察指标

临床妊娠率(CPR)、持续妊娠率(OPR)和卵巢过度刺激综合征(OHSS)率。

结果

共有 9 项 RCT 纳入本分析。两组胚胎移植的 CPR 相似(相对风险(RR):0.97,95%置信区间(CI):0.85-1.10)。比较两种方案时,年龄、BMI、给予的促性腺激素总剂量、刺激天数和取卵数均无显著差异。对 4 项 RCT 进行荟萃分析后得出结论,与长激动剂方案相比,GnRH 拮抗剂方案可降低严重 OHSS 的发生率(比值比(OR):1.56,95%CI:0.29-8.51)。

结论

就 CPR 而言,GnRH 拮抗剂方案与 GnRH 激动剂长方案相似。然而,对于严重 OHSS,GnRH 拮抗剂方案在 PCOS 患者中明显更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/d836b6b146e5/pone.0091796.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/1b980f261706/pone.0091796.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/e757f0ed2e00/pone.0091796.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/276b884fdb4e/pone.0091796.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/e17136087908/pone.0091796.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/d836b6b146e5/pone.0091796.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/1b980f261706/pone.0091796.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/e757f0ed2e00/pone.0091796.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/276b884fdb4e/pone.0091796.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/e17136087908/pone.0091796.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8df3/3958392/d836b6b146e5/pone.0091796.g005.jpg

相似文献

1
Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.促性腺激素释放激素拮抗剂方案在多囊卵巢综合征患者中是否更优?一项 RCT 的荟萃分析。
PLoS One. 2014 Mar 18;9(3):e91796. doi: 10.1371/journal.pone.0091796. eCollection 2014.
2
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.多囊卵巢综合征患者在体外受精或卵胞浆内单精子注射前和期间使用二甲双胍治疗。
Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD006105. doi: 10.1002/14651858.CD006105.pub4.
3
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.在接受体外受精的高危患者中,促性腺激素释放激素(GnRH)激动剂与GnRH拮抗剂联合治疗后用于诱导卵母细胞成熟可预防卵巢过度刺激综合征的风险:一项前瞻性随机对照研究。
Fertil Steril. 2008 Jan;89(1):84-91. doi: 10.1016/j.fertnstert.2007.02.002. Epub 2007 Apr 26.
4
Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.多囊卵巢综合征患者中采用灵活 GnRH 拮抗剂方案与孕激素预刺激卵巢刺激(PPOS)方案:临床结局和卵巢反应的比较。
Curr Med Sci. 2019 Jun;39(3):431-436. doi: 10.1007/s11596-019-2055-x. Epub 2019 Jun 17.
5
Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.多囊卵巢综合征患者体外受精/卵胞浆内单精子注射周期中,常规 GnRH 拮抗剂方案与长 GnRH 激动剂方案的比较:系统评价和荟萃分析。
Sci Rep. 2022 Mar 15;12(1):4456. doi: 10.1038/s41598-022-08400-z.
6
GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.促性腺激素释放激素拮抗剂与长激动剂方案在体外受精中的应用:一项考虑患者类型的系统评价和荟萃分析。
Hum Reprod Update. 2017 Sep 1;23(5):560-579. doi: 10.1093/humupd/dmx017.
7
[Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].[多囊卵巢综合征女性在控制性卵巢刺激中,与长效促性腺激素释放激素激动剂方案相比,使用促性腺激素释放激素拮抗剂方案会增加早期妊娠丢失风险并降低活产率]
Tunis Med. 2009 Dec;87(12):834-42.
8
In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?多囊卵巢综合征女性卵母细胞体外成熟与促性腺激素释放激素拮抗剂体外受精的比较:能否确定优势?
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:46-50. doi: 10.1016/j.ejogrb.2014.05.013. Epub 2014 Jun 2.
9
Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis.促性腺激素释放激素拮抗剂治疗多囊卵巢综合征患者行体外受精的有效性:系统评价和荟萃分析。
Gynecol Endocrinol. 2013 Mar;29(3):187-91. doi: 10.3109/09513590.2012.736561. Epub 2012 Nov 30.
10
A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial.对于接受体外受精的多囊卵巢综合征女性,在促性腺激素释放激素拮抗剂周期中,短期服用二甲双胍并不能降低卵巢过度刺激综合征的发生率:一项随机安慰剂对照试验。
Hum Reprod. 2016 Dec;31(12):2756-2764. doi: 10.1093/humrep/dew268. Epub 2016 Nov 5.

引用本文的文献

1
Optimizing Ovarian Stimulation for IVF in PCOS Patients: A Novel Day 1 GnRH Antagonist Protocol.优化多囊卵巢综合征患者体外受精的卵巢刺激:一种新型的第1天促性腺激素释放激素拮抗剂方案。
J Clin Med. 2025 Aug 21;14(16):5901. doi: 10.3390/jcm14165901.
2
Impact of Luteinizing Hormone on IVF/ICSI Assisted Reproduction on the Initiation Day of Gonadotropin-releasing Hormone Antagonist Protocol.促黄体生成素对促性腺激素释放激素拮抗剂方案启动日IVF/ICSI辅助生殖的影响
Endocr Metab Immune Disord Drug Targets. 2025;25(5):400-410. doi: 10.2174/0118715303281640240722070348.
3
Interventions to prevent or reduce the incidence and severity of ovarian hyperstimulation syndrome: a systematic umbrella review of the best clinical evidence.

本文引用的文献

1
Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis.促性腺激素释放激素拮抗剂治疗多囊卵巢综合征患者行体外受精的有效性:系统评价和荟萃分析。
Gynecol Endocrinol. 2013 Mar;29(3):187-91. doi: 10.3109/09513590.2012.736561. Epub 2012 Nov 30.
2
A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience.多囊卵巢综合征中促性腺激素释放激素长效激动剂与灵活促性腺激素释放激素拮抗剂方案的前瞻性研究:印度经验
J Hum Reprod Sci. 2012 May;5(2):181-6. doi: 10.4103/0974-1208.101017.
3
Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?
干预措施预防或减少卵巢过度刺激综合征的发生和严重程度:最佳临床证据的系统伞式评价。
Reprod Biol Endocrinol. 2023 Jul 21;21(1):67. doi: 10.1186/s12958-023-01113-6.
4
Assisted Reproductive Technology Outcomes in Women With Heart Disease.患有心脏病的女性的辅助生殖技术结局
Front Cardiovasc Med. 2022 Apr 11;9:842556. doi: 10.3389/fcvm.2022.842556. eCollection 2022.
5
Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.多囊卵巢综合征患者体外受精/卵胞浆内单精子注射周期中,常规 GnRH 拮抗剂方案与长 GnRH 激动剂方案的比较:系统评价和荟萃分析。
Sci Rep. 2022 Mar 15;12(1):4456. doi: 10.1038/s41598-022-08400-z.
6
Cumulative Live Birth Rates After the First ART Cycle Using Flexible GnRH Antagonist Protocol vs. Standard Long GnRH Agonist Protocol: A Retrospective Cohort Study in Women of Different Ages and Various Ovarian Reserve.不同年龄和不同卵巢储备的妇女中,采用灵活 GnRH 拮抗剂方案与标准长 GnRH 激动剂方案进行首次 ART 周期后的累积活产率:一项回顾性队列研究。
Front Endocrinol (Lausanne). 2020 May 8;11:287. doi: 10.3389/fendo.2020.00287. eCollection 2020.
7
Effect of Switching from a Progestin-Primed Ovarian Stimulation Protocol to a Modified Ultra-Long Protocol Among Women Who Had 1 Progestin-Primed Ovarian Stimulation (PPOS) Failure Verses Those Who Had 2 PPOS Failures.对于孕激素预处理促排卵(PPOS)方案失败者中仅 1 次失败者与 2 次失败者,从孕激素预处理方案转换为改良超长方案对其的影响。
Med Sci Monit. 2020 Jan 18;26:e918705. doi: 10.12659/MSM.918705.
8
Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.多囊卵巢综合征评估与管理国际循证指南:不孕症评估与治疗的证据总结及建议
Hum Reprod Open. 2019 Jan 4;2019(1):hoy021. doi: 10.1093/hropen/hoy021. eCollection 2019.
9
Association Between Sex Steroids and Oxidative Status with Vitamin D Levels in Follicular Fluid of Non-obese PCOS and Healthy Women.非肥胖多囊卵巢综合征患者和健康女性卵泡液中性类固醇、氧化状态与维生素D水平之间的关联
J Reprod Infertil. 2019 Jul-Sep;20(3):132-142.
10
The Place of In Vitro Maturation in PCO/PCOS.体外成熟技术在多囊卵巢综合征/多囊卵巢中的地位
Int J Endocrinol. 2018 Jul 31;2018:5750298. doi: 10.1155/2018/5750298. eCollection 2018.
在接受不同 GnRH 类似物控制性卵巢刺激的多囊卵巢综合征患者中,第 3 天 LH/FSH 比值是否影响体外受精结局?
Gynecol Endocrinol. 2012 Jun;28(6):422-4. doi: 10.3109/09513590.2011.633661. Epub 2012 Feb 17.
4
IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.多囊卵巢综合征患者中口服避孕药加 GnRH 激动剂方案与口服避孕药加 GnRH 拮抗剂固定方案的 IVF/ICSI 结局:一项随机试验。
Arch Gynecol Obstet. 2012 Sep;286(3):763-9. doi: 10.1007/s00404-012-2348-9. Epub 2012 May 9.
5
Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF/ICSI.在接受体外受精/卵胞浆内单精子注射的非肥胖和肥胖多囊卵巢综合征患者中,比较卵泡早期和晚期应用促性腺激素释放激素(GnRH)拮抗剂多剂量方案与GnRH激动剂长方案的有效性。
Clin Exp Reprod Med. 2012 Mar;39(1):22-7. doi: 10.5653/cerm.2012.39.1.22. Epub 2012 Mar 31.
6
Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?促性腺激素释放激素拮抗剂方案的荟萃分析:它们是否降低了多囊卵巢综合征患者 OHSS 的风险?
Reprod Biomed Online. 2012 Jan;24(1):6-22. doi: 10.1016/j.rbmo.2011.09.017. Epub 2011 Oct 13.
7
Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial.促性腺激素释放激素拮抗剂方案与长方案中口服避孕药的周期安排:一项随机对照试验。
Fertil Steril. 2011 Sep;96(3):590-3. doi: 10.1016/j.fertnstert.2011.06.022. Epub 2011 Jun 30.
8
Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis.促性腺激素释放激素拮抗剂与长激动剂在多囊卵巢综合征体外受精患者中的比较:一项荟萃分析。
Gynecol Endocrinol. 2011 Mar;27(3):150-5. doi: 10.3109/09513590.2010.526667. Epub 2010 Nov 30.
9
Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients.多囊卵巢综合征患者辅助生殖周期中促性腺激素释放激素激动剂与拮抗剂的比较。
J Obstet Gynaecol Res. 2010 Jun;36(3):605-10. doi: 10.1111/j.1447-0756.2010.01247.x.
10
Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients.OCP 预处理后 GnRH 拮抗剂与长 GnRH 激动剂方案在 PCOS 患者中的比较。
Arch Gynecol Obstet. 2010 Sep;282(3):319-25. doi: 10.1007/s00404-010-1429-x. Epub 2010 Apr 9.